News Markets Second Cannabis Investment For UK Tobacco Firm

Second Cannabis Investment For UK Tobacco Firm

-

Advertising

BRITISH tobacco giant Imperial has demonstrated its ambition in the legal cannabis industry with a second foray into the sector.

A recent £75m investment will provide Canadian firm Auxly Cannabis Group access to Imperial’s vaping technology.

This follows its initial investment into fellow UK firm Oxford Cannabis Technologies (OCT) in June, 2018.

Imperial, which makes the Lambert & Butler and Golden Virginia tobacco brands, say the Auxly move is part of an ongoing diversification strategy, which has seen it develop a growing presence in the heated tobacco and electronic vaping sectors.

Matthew Phillips, Imperial’s Chief Development Officer said: “Diversifying our Next Generation Product portfolio with this investment provides Imperial with further options for future growth and builds on last year’s investment in Oxford Cannabinoid Technologies.” 

Toronto-listed Auxly is strongly focused on developing the ‘Generation 2’ Canadian cannabis products, namely; edibles, vapes and lotions which were approved for sale last last year.

The deal gives Bristol-based Imperial a 19.9% stake in Auxly through a three-year convertible loan at a price of 81 cents per share.

OCT is a medical cannabis research company, Backed by Snoop Dogg’s venture firm and Star Wars actor Patrick Stewart, which says it aims to ‘unravel the secrets of a plant that has been stigmatised for decades’. 

Imperial is the latest consumer goods company to make a foray into cannabis. Last year Marlboro maker Altria Group announced a $2.4 billion investment in Cronos Group. 

Tilray has struck an agreement to collaborate on medical cannabis with Sandoz AG, part of the Novartis pharmaceutical Group and Canada’s Canopy Growth is receiving over $5 billion of investment from alcohol giant Constellation Brands.

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

When Is The Best Time – And With Whom – To Launch The Required Toxicology Tests For A UK CBD Novel Food Pass?

FOOD regulators have unveiled further key details for CBD businesses looking to operate in the UK post-Brexit.

Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

CONFIRMATION that the European Union is looking to treat CBD as a narcotic drug have rocked the...

Europe’s CBD Brexit; On The Continent It’s Now A ‘Drug’ – In The UK It’s A Food

THE next few months look like being crucial for the CBD industry following confirmation the European Union...

£28m UK Horticultural Firm Turns To Cannabis: ‘We are learning More And More About This Fascinating Plant’

WITH the equivalent of over 35 football pitches of covered growing space and the potential to add...

Advertising

New MD To Usher In Era Of Change At Europe’s Largest Cannabis Trade Group

THE new Managing Director of the Cannabis Trades Association says it’s time for a re-set as she...

Can New Irish Government Deliver On Medicinal Cannabis? One-Year-Old Scheme Currently Has No Patients

IN June last year the Irish Government signed-off on its five-year medicinal cannabis programme - but no...

Must read

Advertising

You might also likeRELATED
Recommended to you